Virpax Pharmaceuticals | 8-K: Current report
May 2 16:05 ET
Virpax Pharmaceuticals | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
May 2 06:10 ET
Virpax Pharmaceuticals | 8-K: Current report
Apr 30 07:40 ET
Virpax Pharmaceuticals | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Apr 26 17:21 ET
Virpax Pharmaceuticals | S-1: General form for registration of securities under the Securities Act of 1933
Apr 18 16:22 ET
Virpax Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Apr 5 16:11 ET
Virpax Pharmaceuticals | 8-K: Current report
Apr 3 16:10 ET
Virpax Pharmaceuticals | 8-K: Current report
Mar 26 07:34 ET
Virpax Pharmaceuticals | 8-K: Current report
Mar 18 06:34 ET
Virpax Pharmaceuticals | 8-K: Current report
Mar 1 16:13 ET
Virpax Pharmaceuticals | 8-K: Current report
Dec 29, 2023 00:00 ET
Virpax Pharmaceuticals | 8-K: Current report
Dec 13, 2023 08:30 ET
Virpax Pharmaceuticals | DEF 14A: Definitive information statements
Dec 7, 2023 09:08 ET
Virpax Pharmaceuticals | 8-K: Current report
Dec 7, 2023 08:58 ET
Virpax Pharmaceuticals | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Nov 21, 2023 16:57 ET
Virpax Pharmaceuticals | 8-K: Current report
Nov 17, 2023 07:30 ET
Virpax Pharmaceuticals | 8-K: Current report
Nov 17, 2023 07:15 ET
Virpax Pharmaceuticals | 8-K: VIRPAX PHARMACEUTICALS REPORTS 2023 THIRD QUARTER RESULTS AND RECENT DEVELOPMENTS
Nov 16, 2023 16:51 ET
Virpax Pharmaceuticals | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
Nov 15, 2023 15:03 ET
Virpax Pharmaceuticals | 8-K: Current report
Oct 11, 2023 16:10 ET
No Data
No Data